Goode R K, Auclair P L, Ellis G L
Department of Oral and Maxillofacial Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA.
Cancer. 1998 Apr 1;82(7):1217-24. doi: 10.1002/(sici)1097-0142(19980401)82:7<1217::aid-cncr2>3.0.co;2-c.
The authors had previously conducted an investigation of minor salivary gland mucoepidermoid carcinoma, in which they demonstrated that certain clinical and histopathologic features were useful in predicting biologic outcome. The current study investigated the usefulness of these features in determining the prognoses of patients with mucoepidermoid carcinomas of the major salivary glands.
Clinical data and 15 histopathologic features were compared in 4 patient groups based on outcome after initial treatment. The outcome groups were 1) survival without disease, 2) survival with tumor recurrence only, 3) survival with metastasis, and 4) death related to tumor. A numeric score was assigned to each unfavorable histopathologic feature. Low grade tumors had scores of 0-4. Intermediate grade tumors scored 5 or 6. High grade tumors had scores higher than 6.
Most patients (75%) were tumor free after the initial treatment. Twenty-one patients (9%) had local recurrence only, 12 (5%) demonstrated metastasis and survived, and 25 patients (11%) died of their disease.
Clinical features associated with metastasis or death were more advanced age, tumor size, and preoperative symptoms. Histopathologic features that correlated with poor outcome were cystic component less than 20%, 4 or more mitotic figures per 10 high-power fields, neural involvement, necrosis, and anaplasia. All five of these histopathologic features demonstrated statistical prognostic significance when parotid gland tumors from Groups 1 and 4 were compared (P < 0.001). The point-based grading system demonstrated a statistically significant correlation with outcome for parotid tumors but not for submandibular tumors. The authors' findings indicate that patients with tumors of equal histopathologic grade have a better prognosis when their tumors are in the parotid gland than when their tumors are in the submandibular gland. Six of eight submandibular tumors that metastasized or resulted in death were low grade lesions, and none were high grade.
作者之前对小涎腺黏液表皮样癌进行了一项研究,其中他们证明某些临床和组织病理学特征有助于预测生物学转归。本研究调查了这些特征在确定大涎腺黏液表皮样癌患者预后方面的有用性。
根据初始治疗后的转归,将4组患者的临床数据和15项组织病理学特征进行比较。转归组分别为:1)无病生存;2)仅肿瘤复发生存;3)有转移生存;4)与肿瘤相关死亡。为每个不利的组织病理学特征赋予一个数值评分。低级别肿瘤评分为0 - 4分。中级别的肿瘤评分为5或6分。高级别肿瘤评分高于6分。
大多数患者(75%)在初始治疗后无肿瘤。21例患者(9%)仅出现局部复发,12例(5%)出现转移但存活,25例患者(11%)死于疾病。
与转移或死亡相关的临床特征为年龄较大、肿瘤大小和术前症状。与不良转归相关的组织病理学特征包括囊性成分少于20%、每10个高倍视野有4个或更多有丝分裂象、神经受累、坏死和间变。当比较第1组和第4组腮腺肿瘤时,所有这五项组织病理学特征均显示出统计学预后意义(P < 0.001)。基于点数的分级系统显示与腮腺肿瘤的转归有统计学显著相关性,但与下颌下腺肿瘤无关。作者的研究结果表明,组织病理学分级相同的肿瘤患者,肿瘤位于腮腺时的预后比位于下颌下腺时更好。发生转移或导致死亡的8例下颌下腺肿瘤中有6例为低级别病变,无高级别病变。